Racial and ethnic disparities in benign gynecologic conditions and associated surgeries

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 6, 2010, Pages 514-521

  Jacoby, Vanessa L ^a   Fujimoto, Victor Y ^a   Giudice, Linda C ^a   Kuppermann, Miriam ^a   Washington, A Eugene ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

benign gynecology condition; fibroid tumor; surgery

Indexed keywords

ENDOMETRIOSIS; ETHNIC DIFFERENCE; GYNECOLOGIC DISEASE; GYNECOLOGIC SURGERY; HEALTH DISPARITY; HUMAN; HYSTERECTOMY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RACISM; REVIEW; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; UTERUS MYOMA;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; ENDOMETRIOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; UTERINE DISEASES; UTERINE NEOPLASMS;

EID: 77952744760     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.02.039     Document Type: Review

References (82)

1. National healthcare disparities report (2003), Agency for Healthcare Research and Quality, Rockville, MD
2. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in healthcare (2003) Washington, DC
3. Dehlendorf C., Bryant A.S., Huddleston H.G., Jacoby V.L., and Fujimoto V.Y. Health disparities: definitions and measurements. Am J Obstet Gynecol 202 (2010) 214-220
4. Kjerulff K.H., Langenberg P., Seidman J.D., Stolley P.D., and Guzinski G.M. Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41 (1996) 483-490
5. Moore A.B., Flake G.P., Swartz C.D., et al. Association of race, age and body mass index with gross pathology of uterine fibroids. J Reprod Med 53 (2008) 90-96
6. Templeman C., Marshall S.F., Clarke C.A., et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril 92 (2009) 1436-1446
7. Day Baird D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188 (2003) 100-107
8. Marshall L.M., Spiegelman D., Barbieri R.L., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90 (1997) 967-973
9. Faerstein E., Szklo M., and Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study: I, African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 153 (2001) 1-10
10. Wilcox L.S., Koonin L.M., Pokras R., Strauss L.T., Xia Z., and Peterson H.B. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 83 (1994) 549-555
11. Huyck K.L., Panhuysen C.I., Cuenco K.T., et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol 198 (2008) 168.e1-168.e9
12. Baird D.D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. Association of physical activity with development of uterine leiomyoma. Am J Epidemiol 165 (2007) 157-163
13. Peddada S.D., Laughlin S.K., Miner K., et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci USA 105 (2008) 19887-19892
14. Roth T.M., Gustilo-Ashby T., Barber M.D., and Myers E.R. Effects of race and clinical factors on short-term outcomes of abdominal myomectomy. Obstet Gynecol 101 (2003) 881-884
15. Ishikawa H., Reierstad S., Demura M., et al. High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab 94 (2009) 1752-1756
16. Othman E.E., and Al-Hendy A. Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 22 (2008) 589-601
17. Al-Hendy A., and Salama S.A. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril 86 (2006) 686-693
18. Al-Hendy A., and Salama S.A. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 13 (2006) 136-144
19. Gooden K.M., Schroeder J.C., North K.E., et al. Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci 14 (2007) 117-120
20. Wise L.A., Palmer J.R., Harlow B.L., et al. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health study. Hum Reprod 19 (2004) 1746-1754
21. Wise L.A., Palmer J.R., Spiegelman D., et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 16 (2005) 346-354
22. Pan L., Galuska D.A., Sherry B., et al. Differences in prevalence of obesity among black, white, and Hispanic adults - United States, 2006-2008. MMWR Morb Mortal Wkly Rep 58 (2009) 740-744
23. Kurian A.K., and Cardarelli K.M. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis 17 (2007) 143-152
24. Mensah G.A., Mokdad A.H., Ford E.S., Greenlund K.J., and Croft J.B. State of disparities in cardiovascular health in the United States. Circulation 111 (2005) 1233-1241
25. Sharma S., Malarcher A.M., Giles W.H., and Myers G. Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis 14 (2004) 43-48
26. Cook J.D., Davis B.J., Goewey J.A., Berry T.D., and Walker C.L. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats. Reprod Sci 14 (2007) 121-136
27. Greathouse K.L., Cook J.D., Lin K., et al. Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol. Reprod Sci 15 (2008) 765-778
28. Hodges L.C., Hunter D.S., Bergerson J.S., Fuchs-Young R., and Walker C.L. An in vivo/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma. Ann N Y Acad Sci 948 (2001) 100-111
29. Newbold R.R., Jefferson W.N., and Padilla-Banks E. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24 (2007) 253-258
30. Ranjit N., Siefert K., and Padmanabhan V. Bisphenol-A and disparities in birth outcomes: a review and directions for future research. J Perinatol 30 (2010) 2-9
31. Giudice L.C., and Kao L.C. Endometriosis. Lancet 364 (2004) 1789-1799
32. Houston D.E. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev 6 (1984) 167-191
33. Cavanagh W.V. Fertility in the etiology of endometriosis. Am J Obstet Gynecol 61 (1951) 539-547
34. Scott R.B., and Te L.R. External endometriosis: the scourge of the private patient. Ann Surg 131 (1950) 697-720
35. Weed J.C. Endometriosis in the Negro. Ann Surg 141 (1955) 615-620
36. Ridley J.H. The histogenesis of endometriosis: a review of facts and fancies. Obstet Gynecol Surv 23 (1968) 1-35
37. Chatman D.L. Endometriosis and the black woman. J Reprod Med 16 (1976) 303-306
38. Chatman D.L. Endometriosis in the black woman. Am J Obstet Gynecol 125 (1976) 987-989
39. Sangi-Haghpeykar H., and Poindexter III A.N. Epidemiology of endometriosis among parous women. Obstet Gynecol 85 (1995) 983-992
40. Arumugam K., and Templeton A.A. Endometriosis and race. Aust N Z J Obstet Gynaecol 32 (1992) 164-165
41. Hasson H.M. Incidence of endometriosis in diagnostic laparoscopy. J Reprod Med 16 (1976) 135-138
42. Missmer S.A., Hankinson S.E., Spiegelman D., Barbieri R.L., Marshall L.M., and Hunter D.J. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 160 (2004) 784-796
43. Kirshon B., Poindexter III A.N., and Fast J. Endometriosis in multiparous women. J Reprod Med 34 (1989) 215-217
44. Matalliotakis I.M., Cakmak H., Fragouli Y.G., Goumenou A.G., Mahutte N.G., and Arici A. Epidemiological characteristics in women with and without endometriosis in the Yale series. Arch Gynecol Obstet 277 (2008) 389-393
45. Kado N., Kitawaki J., Obayashi H., et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 17 (2002) 897-902
46. Duvernoy C.S., Rose P.A., Kim H.M., Kehrer C., and Brook R.D. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. J Womens Health (Larchmt) 16 (2007) 963-970
47. Xie J., Wang S., He B., et al. Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population. Fertil Steril 92 (2009) 54-60
48. Tempfer C.B., Simoni M., Destenaves B., and Fauser B.C. Functional genetic polymorphisms and female reproductive disorders: part II, endometriosis. Hum Reprod Update 15 (2009) 97-118
49. Missmer S.A., Hankinson S.E., Spiegelman D., Barbieri R.L., Michels K.B., and Hunter D.J. In utero exposures and the incidence of endometriosis. Fertil Steril 82 (2004) 1501-1508
50. Louis G.M., Weiner J.M., Whitcomb B.W., et al. Environmental PCB exposure and risk of endometriosis. Hum Reprod 20 (2005) 279-285
51. Mayani A., Barel S., Soback S., and Almagor M. Dioxin concentrations in women with endometriosis. Hum Reprod 12 (1997) 373-375
52. Heilier J.F., Nackers F., Verougstraete V., Tonglet R., Lison D., and Donnez J. Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril 84 (2005) 305-312
53. Rier S., and Foster W.G. Environmental dioxins and endometriosis. Semin Reprod Med 21 (2003) 145-154
54. Porpora M.G., Ingelido A.M., di Domenico A., et al. Increased levels of polychlorobiphenyls in Italian women with endometriosis. Chemosphere 63 (2006) 1361-1367
55. Niskar A.S., Needham L.L., Rubin C., et al. Serum dioxins, polychlorinated biphenyls, and endometriosis: a case-control study in Atlanta. Chemosphere 74 (2009) 944-949
56. Pauwels A., Schepens P.J., D'Hooghe T., et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Hum Reprod 16 (2001) 2050-2055
57. Centers for Disease Control. Third national report on human exposure to environmental chemicals (2005), Centers for Disease Control, Atlanta, GA
58. Keshavarz H., Kieke B.A., and Marchbanks P. Hysterectomy surveillance: United States, 1994-99. MMWR CDC Surveill Summ 51 (2002) 1-8
59. Wu J.M., Wechter M.E., Geller E.J., Nguyen T.V., and Visco A.G. Hysterectomy rates in the United States, 2003. Obstet Gynecol 110 (2007) 1091-1095
60. Kjerulff K., Langenberg P., and Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health 83 (1993) 106-108
61. Learman L.A., Kuppermann M., Gates E., Gregorich S.E., Lewis J., and Washington A.E. Predictors of hysterectomy in women with common pelvic problems: a uterine survival analysis. J Am Coll Surg 204 (2007) 633-641
62. Bower J.K., Schreiner P.J., Sternfeld B., and Lewis C.E. Black-white differences in hysterectomy prevalence: the CARDIA study. Am J Public Health 99 (2009) 300-307
63. Kjerulff K.H., Guzinski G.M., Langenberg P.W., Stolley P.D., Moye N.E., and Kazandjian V.A. Hysterectomy and race. Obstet Gynecol 82 (1993) 757-764
64. Powell L.H., Meyer P., Weiss G., et al. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues 15 (2005) 179-186
65. Kuppermann M., Learman L., Schembri M., et al. Predictors of hysterectomy use and satisfaction. Obstet Gynecol 115 (2010) 543-551
66. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
67. Sentell T.L., and Halpin H.A. Importance of adult literacy in understanding health disparities. J Gen Intern Med 21 (2006) 862-866
68. Paasche-Orlow M.K., Parker R.M., Gazmararian J.A., Nielsen-Bohlman L.T., and Rudd R.R. The prevalence of limited health literacy. J Gen Intern Med 20 (2005) 175-184
69. Shelton A.J., Lees E., and Groff J.Y. Hysterectomy: beliefs and attitudes expressed by African-American women. Ethn Dis 11 (2001) 732-740
70. Hakim R.B., Benedict M.B., and Merrick N.J. Quality of care for women undergoing a hysterectomy: effects of insurance and race/ethnicity. Am J Public Health 94 (2004) 1399-1405
71. Brett K.M., and Higgins J.A. Hysterectomy prevalence by Hispanic ethnicity: evidence from a national survey. Am J Public Health 93 (2003) 307-312
72. Lewis C.E., Groff J.Y., Herman C.J., McKeown R.E., and Wilcox L.S. Overview of women's decision making regarding elective hysterectomy, oophorectomy, and hormone replacement therapy. J Womens Health Gend Based Med 9 suppl 2 (2000) S5-S14
73. Tortolero-Luna G., Byrd T., Groff J.Y., Linares A.C., Mullen P.D., and Cantor S.B. Relationship between English language use and preferences for involvement in medical care among Hispanic women. J Womens Health (Larchmt) 15 (2006) 774-785
74. Hautaniemi S.I., and Leidy Sievert L. Risk factors for hysterectomy among Mexican-American women in the US southwest. Am J Hum Biol 15 (2003) 38-47
75. Abenhaim H.A., Azziz R., Hu J., Bartolucci A., and Tulandi T. Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies. J Minim Invasive Gynecol 15 (2008) 11-15
76. Jacoby V.L., Autry A., Jacobson G., Domush R., Nakagawa S., and Jacoby A. Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches. Obstet Gynecol 114 (2009) 1041-1048
77. Wolf M.S., Knight S.J., Lyons E.A., et al. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology 68 (2006) 89-93
78. Guller U., Jain N., Curtis L.H., Oertli D., Heberer M., and Pietrobon R. Insurance status and race represent independent predictors of undergoing laparoscopic surgery for appendicitis: secondary data analysis of 145,546 patients. J Am Coll Surg 199 (2004) 567-577
79. Smith L.H., Waetjen L.E., Paik C.K., and Xing G. Trends in the safety of inpatient hysterectomy for benign conditions in California, 1991-2004. Obstet Gynecol 112 (2008) 553-561
80. Jacoby V.L., Vittinghoff E., Nakagawa S., et al. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol 113 (2009) 1259-1267
81. Weng H.H., McBride C.M., Bosworth H.B., Grambow S.C., Siegler I.C., and Bastian L.A. Racial differences in physician recommendation of hormone replacement therapy. Prev Med 33 (2001) 668-673
82. Marsh J.V., Brett K.M., and Miller L.C. Racial differences in hormone replacement therapy prescriptions. Obstet Gynecol 93 (1999) 999-1003